Merck & Co

In this undated file image provided by Merck & Co. shows their new antiviral medication. The pharmaceutical Merck has agreed to allow other drugmakers worldwide to make its Covid-19 treatment, the first pill that has been shown to be effective against the disease, in a move aimed at helping millions of people in poorer countries access to the drug. In a statement on Wednesday, Oct. 27, 2021, the UN-backed Medicines Patent Pool said it had signed a voluntary licensing agreement for molnupiravir with Merck and its partner Ridgeback Biotherapeutics. (Merck & Co. via AP, File)
Covid-19 in Bangladesh

Merck agrees to let other drug makers make its Covid pill

The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, US, July 12, 2018. REUTERS/Brendan McDermid
Coronavirus chronicle

Merck seeks first US FDA authorisation for Covid-19 tablet

An experimental COVID-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. Merck & Co Inc/Handout via REUTERS
Coronavirus chronicle

Merck's Covid-19 pill should be combined with other treatments to avert resistance, says expert

Family doctor Vera Maria Soditt vaccinates a patient at her home with a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine in Cologne, Germany, March 28, 2021. REUTERS/Thilo Schmuelgen
Coronavirus chronicle

Germany still working on recommendation for Covid-19 booster shot